![An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/a58b2e05-56ce-4538-aefa-b0f74c2aada3/gr1.jpg)
An integrated nomogram combining deep learning, Prostate Imaging–Reporting and Data System (PI-RADS) scoring, and clinical variables for identification of clinically significant prostate cancer on biparametric MRI: a retrospective multicentre study - The
Nutrition and Prostate Cancer: Making Healthy Diet Decisions | Memorial Sloan Kettering Cancer Center
![Validation of user-friendly models predicting extracapsular extension in prostate cancer patients - ScienceDirect Validation of user-friendly models predicting extracapsular extension in prostate cancer patients - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2214388222000273-figs2.jpg)
Validation of user-friendly models predicting extracapsular extension in prostate cancer patients - ScienceDirect
![Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study - European Urology Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study - European Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/e1a50048-62a3-4feb-b52d-f6d87e65b55b/gr2.jpg)
Predicting Prostate Cancer Death with Different Pretreatment Risk Stratification Tools: A Head-to-head Comparison in a Nationwide Cohort Study - European Urology
![Prostate cancer screening—when to start and how to screen? - Kohestani - Translational Andrology and Urology Prostate cancer screening—when to start and how to screen? - Kohestani - Translational Andrology and Urology](https://cdn.amegroups.cn/journals/amepc/files/journals/3/articles/18018/public/18018-PB3-R1.png/w300)
Prostate cancer screening—when to start and how to screen? - Kohestani - Translational Andrology and Urology
![Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging | Insights into Imaging | Full Text Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging | Insights into Imaging | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13244-022-01265-w/MediaObjects/13244_2022_1265_Fig1_HTML.png)
Cost-effectiveness of the implementation of [68Ga]Ga-PSMA-11 PET/CT at initial prostate cancer staging | Insights into Imaging | Full Text
![Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fbjc.2017.47/MediaObjects/41416_2017_Article_BFbjc201747_Fig1_HTML.jpg)
Multicenter prospective evaluation of the reliability of the combined use of two models to predict non-sentinel lymph node status in breast cancer patients with metastatic sentinel lymph nodes: the MSKCC nomogram and
![Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center | Journal of Urology Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center | Journal of Urology](https://www.auajournals.org/cms/asset/57cd23a1-cfd8-4e19-80b1-1d21ce7d2fb6/juro.2020.203.issue-6.cover.jpg)
Risk of Metastasis in Men with Grade Group 2 Prostate Cancer Managed with Active Surveillance at a Tertiary Cancer Center | Journal of Urology
![Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy - ScienceDirect Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S1078143919303242-gr1.jpg)
Evaluation of MSKCC Preprostatectomy nomogram in men who undergo MRI-targeted prostate biopsy prior to radical prostatectomy - ScienceDirect
![Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care](https://cambridgeprostatecancer.com/wp-content/uploads/cam1-min-768x431.jpg)
Improving Disease Prognostics - Cambridge Prostate Cancer - facilitating world class research, diagnostics and care
![The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort | SpringerLink The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1245%2Fs10434-018-6756-3/MediaObjects/10434_2018_6756_Fig2_HTML.png)
The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort | SpringerLink
![External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik - External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik -](https://bjui-journals.onlinelibrary.wiley.com/cms/asset/702eb4af-ba4c-45fa-bf34-dd7f2d2bd623/bju15376-fig-0003-m.jpg)
External validation of the Memorial Sloan Kettering Cancer Centre and Briganti nomograms for the prediction of lymph node involvement of prostate cancer using clinical stage assessed by magnetic resonance imaging - Soeterik -
![Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer - Urology Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer - Urology](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/801646/5850663/gr1.jpg)
Use of nomograms to predict the risk of disease recurrence after definitive local therapy for prostate cancer - Urology
![Developing a national, Web-based, patient-focused, prostate cancer data monitoring system | THE "NEW" PROSTATE CANCER INFOLINK Developing a national, Web-based, patient-focused, prostate cancer data monitoring system | THE "NEW" PROSTATE CANCER INFOLINK](https://talkaboutprostatecancer.files.wordpress.com/2009/12/mskcc-image-d.jpg?w=584)